Quantitative evaluation of isothiocyanates as substrates and inhibitors of P-glycoprotein

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 9, 2003, Pages 1251-1257

  Barecki Roach, Mary ^a   Wang, Er Jia ^a   Johnson, William W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; BENZYL ISOTHIOCYANATE; CARCINOGEN; CYTOTOXIN; DAUNORUBICIN; ENZYME; GLYCOPROTEIN P; GRAMICIDIN; ISOTHIOCYANIC ACID DERIVATIVE; LDS 751; PHENETHYL ISOTHIOCYANATE; PHENYLBUTYL ISOTHIOCYANATE; PHENYLPROPYL ISOTHIOCYANATE; RHODAMINE 123; TOXIN; UNCLASSIFIED DRUG; VALSPODAR; XENOBIOTIC AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ISOLATION; CELL MEMBRANE; DIET; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE; FOOD ANALYSIS; IC 50; INTESTINE; LIPOPHILICITY; MACROMOLECULE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL SURVIVAL; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; INHIBITORY CONCENTRATION 50; ISOTHIOCYANATES; KINETICS; MICE; NIH 3T3 CELLS; ORGANIC CHEMICALS; P-GLYCOPROTEIN;

EID: 0141571102     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021666     Document Type: Article

References (40)

1. Ambudkar, S. V., Cardarelli, C. O., Pashinsky, I., Stein, W. D. (1997) Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J. Biol. Chem. 272: 21 160-21 166
2. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., Gottesman, M. M. (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39: 361-398
3. Borgnia, M. J., Eytan, G. D., Assaraf, Y. G. (1996) Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J. Biol. Chem. 271: 3163-3171
4. Chung, F. L., Morse, M. A., Eklind, K. I., Lewis, J. (1992) Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol. Biomarkers Prev. 1: 383-388
5. Dey, S., Ramanchandra, M., Pastan, I., Gottesman, M. M. (1997) Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl Acad. Sci. USA 94: 10 594-10 599
6. Eytan, G. D., Regev, R., Assaraf, Y. G. (1996) Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. J. Biol. Chem. 271: 3172-3178
7. Gottesman, M. M., Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427
8. Gottesman, M. M., Pastan, I., Ambudkar, S. V. (1996) P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Dev. 6: 610-617
9. Hecht, S. S. (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metab. Rev. 32: 395-411
10. Hrycyna, C. A., Ramachandra, M., Germann, U. A., Cheng, P. W., Pastan, I., Gottesman, M. M. (1999) Both ATP sites of human P-glycoprotein are essential but not symmetric. Biochemistry 38: 13 887-13 899
11. Ioannides, C. (2002) Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32: 451-478
12. Kerr, K. M., Sauna, Z. E., Ambudkar, S. V. (2001) Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates. J. Biol. Chem. 276: 8657-8664
13. Litman, T., Zeuthen, T., Skovsgaard, T., Stein, W. (1997) Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. Biochim. Biophys. Acta 1361: 169-176
14. Loo, T. W., Clarke, D. M. (1995) Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. J. Biol. Chem. 270: 22 957-22 961
15. Pascaud, C., Garrigos, M., Orlowski, S. (1998) Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem. J. 333: 351-358
16. Ramachandra, M., Ambudkar, S. V., Gottesman, M. M., Pastan, I., Hrycyna, C. A. (1996) Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Mol. Biol. Cell 7: 1485-1498
17. Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., Scarborough, G. A. (1992) Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267: 4854-4858
18. Sauna, Z. E., Ambudkar, S. V. (2000) Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc. Natl Acad. Sci. USA 97: 2515-2520
19. Sauna, Z. E., Ambudkar, S. V. (2001) Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein: The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes. J. Biol. Chem. 276: 11 653-11 661
20. Senior, A. E., Bhagat, S. (1998) P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites. Biochemistry 37: 831-836
21. Shapiro, A. B., Ling, V. (1997a) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250: 130-137
22. Shapiro, A. B., Ling, V. (1997b) Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. Eur. J. Biochem. 250: 122-129
23. Shapiro, A. B., Ling, V. (1998) Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. Eur. J. Biochem. 254: 189-193
24. Sharom, F. J., Yu, X., Doige, C. A. (1993) Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268: 24 197-24 202
25. Sharom, F. J., Liu, R., Romsicki, Y., Lu, P. (1999) Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochim. Biophys. Acta 1461: 327-345
26. Smith, T. J., Yang, C. S. (2000) Effect of organosulfur compounds from garlic and cruciferous vegetables on drug metabolism enzymes. Drug Metab. Drug Interact. 17: 23-49
27. Stein, W. D. (1997) Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77: 545-590
28. Talalay, P., Fahey, J. W. (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J. Nutr. 131 (11 Suppl.): 3027S-3033S
29. Tookey, H. L., Van Etten, C. H., Daxenbichler, M. E. (1980) Glucosinolates. In: I. E. Liener (ed.) Toxic Constituents of Plant Stuffs. Academic Press, New York, pp 103-142
30. Tseng, E., Kamath, A., Morris, M. E. (2002) Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine. Pharm. Res. 19: 1509-1515
31. Van Helvoort, A., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., Van Meer G. (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517
32. Wang, E.-J., Casciano, C. N., Clement, R. P., Johnson, W. W. (2000a) Two transport binding sites of P-glycoprotein are unequal yet contingent: Initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependency. Biochim. Biophys. Acta 1481: 63-74
33. Wang, E.-J., CAsciano, C. N., Clement, R. P., Johnson, W. W. (2000b) Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: Evidence for half-of-the-sites reactivity. Arch. Biochem. Biophys. 383; 91-98
34. Wang, E.-J., Casciano, C. N., Clement, R. P., Johnson, W. W. (200c) In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. Drug Metab. Dispos. 28: 522-528
35. Wang, E.-J., Casciano, C. N., Clement, R. P., Johnson, W. W. (2001a) Active transport of fluorescent P-glycoprotein substrates: Evaluation as markers and interaction with inhibitors. Biochem. Biophys. Res. Commun. 289: 580-585
36. Wang, E.-J., Lew, K., Barecki, M. E., Casciano, C. N., Clement, R. P., Johnson, W. W. (2001b) Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4. Chem. Res. Toxicol. 14: 1596-1603
37. Wang, G., Pincheira, R., Zhang, J.-T. (1998) Dissection of drug-binding-induced conformational changes in P-glycoprotein. Eur. J. Biochem. 255: 383-390
38. Ye, L., Dinkova-Kostova, A. T., Wade, K. L., Zhang, Y., Shapio, T. A., Talalay, P. (2002) Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: Pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin. Chim. Acta 316: 43-53
39. Zhang, Y. (2001) Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 22: 425-431
40. Zhang, Y., Callaway, E. C. (2002) High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem. J. 364 (Pt 1): 301-307